Dexlansoprazole with CAS 138530-94-6 is a proton pump inhibitor that is marketed by Takeda Pharmaceuticals.
Dexlansoprazole (CAS 138530-94-6), Chemically, is an enantiomer of lansoprazole. The compound was launched in the US for use in the treatment and maintenance of patients with erosive oesophagitis and non-erosive gastro-oesophageal reflux disease (GERD or GORD).
|